MMP3 and pulmonary fibrosis: We found in this model that circulating levels of CXCL9, DKK3, and MMP3 were already significantly elevated in day 18 samples, on average 10 days before the diagnosis of cGVHD, including pulmonary fibrosis (Figure 2).